Early Use of Vasopressin in Post-Fontan Management

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Circulatory Perfusion Disorder, Congenital Heart Disease, Single-ventricle

In brief

This is an investigator initiated, prospective, single-center, double-blinded, randomized, placebo-controlled trial of post-operative low dose vasopressin infusions as an early treatment of low systemic perfusion in pediatric patients following Fontan palliation.

Key facts

Study ID

NCT03088345

Run by

Medical College of Wisconsin

People needed

20

Starts

2017-03-06

Expected to finish

2019-01-28

Last updated by the study team

2020-07-07

Who can join

Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Planned completion of Fontan palliation
• English or Spanish speaking
• Completion of Informed Consent

You may not qualify if…

• Previous failed attempts at Fontan completion with subsequent takedown
• Planned concomitant atrioventricular valvuloplasty or neoaortic valve or arch reconstruction at the time of Fontan completion
• History of renal failure requiring renal replacement therapy
• Absence of informed consent

Where it is running

• Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.